Normal leukocyte functional capacity was investigated by evaluation of phagocytosis of opsonised yeast cells in a radiometric test system. After incubation with dialysis membranes (different cellulosic membranes, polysulfon membrane (PS), polymethylmetacrylate membrane (PMMN), the phagocytosis index, expressed as percent decrease with respect to initial values without membrane, decreased by 10%–25%. The most pronounced effect was observed with PS, cuprophane, modified cellulose and PMMA. The results are not related to differences in the viability of PMN during the test procedure; dead PMN amounted to about 4–6.5%. A significant increase in β-NAG and β-Gluc activities was released in the supernatants of the phagocytosis suspensions. This increase activity can be explained by the phagocytosis of PMN but it was not influenced by membrane contact. There was no influence of membrane contact or phagocytosis activity of PMN on the β2M concentration in the supernatant demonstrating that no in vitro generation during incubation with either membrane exists.
BremmKD, KönigW.Die Rolle der neutrophilen Granulocyten bei der mikrobiellen Infektabwehr. Dtsch med Wschr1988; 113: 392–402.
2.
PetersenJO, KnudsenF, JersildG.Acute effect of hemodialysis on neutrophil migration: impact in humeral and cellular function. Kidney Int1988; 24 (Suppl 33): 86–9.
3.
BergesioF, MonzaniG, ManescalchiF, BoccabiancaJ, PassalevaA, FrizziV.Leukocytes, eosinophils and complement function during hemodialysis with polysulfon and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylnitril. Blood Purification1988; 6: 16–26.
4.
FarrellPC. Biological consequences of blood-membrane interactions. In: SmebyLC, ForstadS, WiderveTE, eds. Immune and metabolic aspects of therapeutic blood purification systems. Proc Int Symp Trondheim 1985. Basel, Karger1986; 49–51.
5.
HörlWH, SteinhauerMD, SchollmeyerP.Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. Kidney Int1985; 28: 791–4.
6.
LemkeHD. Comparison of parameters for blood compatibility assessment of polymers (membranes) in vitro. In: SmebyLC, ForstadS, WiderveTE, eds. Immune and Metabolic aspects of therapeutic blood purification systems. Proc Int Symp Trondheim 1985; Basel: Karger, 1986; 179–83.
7.
SüssJ, BakacsT, BalazeC.The phagocytosis capacity assay: a new radiometric phagocytosis test for clinical use. J Immunol Methods1982a; 53: 69–75.
8.
FindlayJ, LevyGA, MarchC.Inhibition of glycosidases by aldono-lactones of corresponding configuration. Biochem J1958; 69: 467–74.
9.
SzaszG.Die Bestimmung der β-Glucuronidase-Aktivität im Serum mit p-Nitrophenyl-Glucuronid. Clin Chem Acta1967; 15:275–82.
10.
HendersonL, ChenowethD.Cellulose membranes - time for a change?Contrib Nephrol1985; 44: 112–26.
11.
SteinG, MarxST, SüssJ, MüllerA.Effect of different membranes on leukocyte (PMN) phagocytosis (in press).
12.
CoratelliP, RizziR, SchenaA, PavensV, SpecchiaG, LisoV.Neutrophil function during hemodialysis: effects of three different membranes. In: SmebyLC, ForstadS, WiderveTE, eds. Immune and metabolic aspects of therapeutic blood purification systems. Proc Int Symp Trondheim 1985. Basel: Karger, 1986; 137–43.
13.
CostaAN, StefoniS, BuscareliA, Phagocyte function in dialysis patients. In: SmebyLC, ForstadS, WiderveTE, eds. Immune and metabolic aspects of therapeutic blood purification systems. Proc Int Symp Trondheim 1985.Basel: Karger, 1986; 174–8.
14.
AparicioM, VincendeauPh, GrinH, Effect of low-protein diet on chemiluminescence production by leukocytes from uremic patients. Nephron1988; 48: 315–8.
15.
BoschT, SchmidtB, SamtlebenW, GurlandHJ. Biocompatibility and clinical performances of a new modified cellulose membrane. Clin Nephrol1986; 1 (Suppl 26): 22–9.
16.
HällgrenR, VengeP, DanielsonBG. Neutrophil and eosinophil degranulation during hemodialysis are mediated by the dialysis membrane. Nephron1982; 31: 329–34.
17.
HeidlandA, HörlWH, HellerN, HeineH, NeumannS, HeidbrederE.Proteolytic enzyme and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. Kidney Int1983; 16 (Suppl. 23): 27–36.
18.
HeidlandA, HörlWH, HellerN, Granulocyte lysosomal factors and plasma eleastase in uremia: a potential factor of catabolism. Klin Wochenschr1984; 62: 218–24.
19.
RitcheyEE, WallinJD, ShahSV. Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int1981; 19: 349–58.
20.
RôckelA, AbdelhamidS, FiegelP, OttoM, ThielCI, WalbD.Neuere Gesichtspunkt zu hämodialysebedingten Biocompatibilitätsproblemen. Nieren- und Hochdruckkr1985; 14: 178–83.
21.
SchaeferRM, HerfsN, OrmannsW, HörlWH, HeidlandW.Change of elastase and cathepsin G content in polymorphonuclear leukocytes during hemodialysis. Clin Nephrol1988; 29: 307–11.
22.
SmolenJE, WeissmannG.The granulocyte: metabolic properties and mechanism of lysosomal enzyme release. In: HavemannJ, JanoffA, eds. Neutral protease of human polymorphonuclear leukocytes.Baltimore, München: Urban und Schwarzenberg, 1978; 56–76.
23.
SteinG, CarlsohnH, SchaeferK, Klinische Bedeutung der β2-Mikroglobulin-Bestimmung (β2M) bei Dialysepatienten. Z Urol Nephral1989; 82: 265–72.
24.
GejyoF, HommaN, SuzukiY, ArakawaM.Serum levels of beta-2 microglobulin as a new form of amyloid plasma in patients undergoing long-term hemodialyses. New Engl J Med1986; 314: 585–6.
25.
HamplH, Bartel-SchwarzeS.LobeckH, SteinH, EulitzM, LinkeRP. Klinik, Morphologie, Biochemie und Immunhistologisch der dialyseassoziierten Amyloidose. Nieren- und Hochdruckkr1987; 16: 173–84.
VincentC, RevillardJP. Beta-2 microglobulin and HLA-related glycoproteins in human urine and serum. Contrib Nephrol1981; 26: 66–88.
30.
ZingraffJ, BeyneP, UrenaP, UzanM, ManNK, Descamps-LatschaB, DrüekeT.Influence of haemodialysis membranes on β2 microglobulin kinetics: in vivo and in vitro studies. Nephrol Dial Transp1988; 3: 284–90.
31.
FlügeJ, GranollerasC, BingelM, β2 microglobulin kinetics during haemodialysis and haemofiltration. Nephrol Dial Transp1987; 1: 223–8.
32.
KamunoK, NanbuM, KasakariS, SakaiT, SakuraiK.Synthesis of beta 2-microglobulin in dialysed patients. Abstr Kidney Int1988; 33: 228.
33.
MoriK, YamagamiS, SugimuraT, Stimulated β2-microglobulin production of lymphocytes in long-term hemodialysis patients. Abstr 10th Int Congr Nephrol, London 1987. Kidney Int1988; 33:160.
34.
KnudsenPJ, NyAK, LiuZ.Beta-2 microglobulin synthesis is increased during activation of human monocytes. Blood Purification1988; 6: 178–87.
